Pendulum Akkermansia review
A scientifically serious probiotic strain with published RCTs behind the organism — and consumer surveys where you'd want product trials
Reviewed August 26, 2026 · Visit pendulumlife.com
What this is: a dietary supplement — not an FDA-approved medicine. It has not been evaluated by the FDA for safety, efficacy or quality, and nothing in this review is medical advice or an endorsement. If you are considering stopping or replacing prescribed medication with any product on this page, talk to your clinician first.
Overview
What Pendulum Akkermansia is
Pendulum is the most scientifically credible company in this set: it runs its own oxygen-free manufacturing facility, co-developed products with Mayo Clinic researchers, and the Akkermansia muciniphila organism has genuine randomized-trial literature, including Nature Medicine publications and work measuring GLP-1 production as an endpoint. Notably, Pendulum's own product page makes no direct GLP-1 claim — its GLP-1 linkage lives in sponsored ongoing trials. The gap between the organism and the bottle is the catch: much of the strongest trial evidence used pasteurized Akkermansia or the company's multi-strain diabetes formula, not necessarily the live-strain capsule sold here, and the headline '91% reduced food cravings' statistic comes from an 80-person customer survey, not a controlled trial.
Active ingredients
| Ingredient | Published dose |
|---|---|
| Akkermansia muciniphila (live, single strain) | 100 million AFU per capsule |
| Chicory inulin (prebiotic) | Per capsule; amount not quantified on page |
Best for
Buyers who want the microbiome angle from the company doing the actual research — with expectations calibrated to organism-level evidence.
Limitations
The jump from promising Nature Medicine papers on an organism to a $54-a-month capsule's effect on your cravings crosses exactly the evidence gap the rest of this category ignores. Pendulum at least labels its surveys honestly.
Evidence rating
Peer-reviewed RCTs
Randomized, controlled human trials exist for this ingredient. Read the notes — trial design and sample size matter.
Claims vs evidence
What the brand says, and what we could verify
The company's mechanism claim is quoted or closely paraphrased from its own site. Of 5 cited studies, we could independently confirm 4 in indexed literature.
The claim
Marketed as fortifying the gut lining, reducing gut permeability and supporting gut health, with cravings impact framed through the gut-brain axis ('may influence… the communication pathway that helps regulate hunger signals'). The company discloses a sponsored two-phase study measuring food cravings and GLP-1 plasma levels, plus a registered triple-blind synbiotic RCT (NCT06213480).
The evidence
The organism has real published RCT history we verified on PubMed: Depommier et al. in Nature Medicine 2019 (pasteurized strain, overweight adults), Zhang et al. in Cell Metabolism 2025 (T2D, efficacy dependent on baseline abundance), Mount et al. in Nature Medicine 2026 (weight-loss maintenance), and Suenaert et al. in Gut Microbes 2026 measuring GLP-1 production endpoints. Pendulum's own Glucose Control formula has a multicenter RCT reporting A1c reductions. But these are organism- and formula-level findings; the specific live-strain Akkermansia consumer capsule lacks its own published head-to-head trial, and the craving statistics are survey-derived.
| Cited study | Reported finding | Independently verified |
|---|---|---|
| Depommier et al., Nat Med 2019;25:1096-1103 | Proof-of-concept RCT of pasteurized A. muciniphila in overweight/obese adults | Confirmed on PubMed |
| Zhang et al., Cell Metab 2025;37:592-605 | 12-week RCT in type 2 diabetes; benefit depended on baseline abundance of the strain | Confirmed on PubMed |
| Mount et al., Nat Med 2026;32:2107-2116 | RCT (n=90) in weight-loss maintenance contexts | Confirmed on PubMed |
| Suenaert et al., Gut Microbes 2026;18:2690689 | RCT including GLP-1 production outcomes in metabolic syndrome | Confirmed on PubMed |
| Pendulum customer survey (n=80) | '91% reduced food cravings' — uncontrolled consumer survey, not a trial | Not verified |
Facts
Regulation, testing, dosing and price
Every figure is published by the brand. Where something is not disclosed, we say so rather than estimating.
- Regulatory status
- Sold as a dietary supplement. Pendulum's own disclaimer: the FDA has not approved or evaluated these statements, and products are not intended to diagnose, treat, cure or prevent disease.
- Third-party testing
- Manufactured in Pendulum's own oxygen-free U.S. facility
- Proprietary strains developed with academic partners
- FSA/HSA eligible per the site
- How it's taken
- One capsule daily with food; refrigeration recommended though stated not required.
- Safety disclosures
- Possible transient gas, bloating, nausea or loose stools resolving within about two weeks; unstudied in pregnancy and breastfeeding; consult-your-provider language included.
- Manufacturer
- Pendulum Therapeutics
- Subscription
- $54 per 30 days on subscription (advertised as 42% off)
- Guarantee
- Full refund within 30 days of first-order delivery, minus shipping and handling
- Price as published
- One-time purchase (30 capsules)$75.00
- Three-month supply (90 capsules)$145.00
Assessment
Pros and cons
Editorial judgment applied to the published facts above.
Pros
- Strongest institutional science in the category — company-affiliated RCTs in major journals
- Honest product page: no inflated on-label GLP-1 promise
- Single-strain clarity with quantified potency (100m AFU)
- Registered ongoing trial specifically measuring GLP-1 plasma levels
Cons
- Best-known trial results used pasteurized bacteria or other formulas — extrapolation required
- Headline craving statistics are customer surveys, not controlled data
- Effective subscription price ($54/mo) exceeds several months of generic metformin
- GLP-1 association currently rests on sponsored, partly unpublished work
Alternatives
If Pendulum Akkermansia isn't what you're after
Calocurb
The strongest evidence base in this category — real peer-reviewed human trials, attached to marketing that still outruns them
Peer-reviewed RCTsThorne Berberine
Dozens of real RCTs exist for berberine — and meta-analyses disagree about whether they add up to meaningful weight loss
Peer-reviewed RCTsPendulum Akkermansia: frequently asked questions
Does Pendulum Akkermansia raise GLP-1?
Why do the Nature Medicine trials not settle it?
How much does it cost?
Sources
- Pendulum — Akkermansia product page
- Pendulum — research and clinical trials
- PubMed — Akkermansia supplementation RCTs
Verified August 26, 2026. Supplement formulations and prices change frequently — confirm current details with the brand.
Medical disclaimer
This review is editorial research about a commercial service. It is not medical advice, and it is not a recommendation to start, stop or change any treatment. GLP-1 medications are prescription drugs with real contraindications and side effects. Decisions about whether they are appropriate for you belong with a qualified clinician who knows your medical history. Prices and terms in this category change frequently — we publish the date each review was verified and link every source, but you should confirm current details with the provider before purchasing.